Suchergebnisse - "Lee, Younglang"

PubPharm (17)

1

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUSCULAR WEAKNESS-RELATED DISEASES COMPRISING ALVERINE, 4-HYDROXY ALVERINE, DERIVATIVE THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

enthalten in: Europäisches Patentamt | 2023

von KWON KI-SUN | LEE YOUNGLANG | YOON JONG HYUN | +4

2

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUSCULAR WEAKNESS-RELATED DISEASES COMPRISING ALVERINE, 4-HYDROXY ALVERINE, DERIVATIVE THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

enthalten in: Europäisches Patentamt | 2023

von KWON KI-SUN | LEE YOUNGLANG | YOON JONG HYUN | +4

3

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUSCULAR WEAKNESS-RELATED DISEASES COMPRISING ALVERINE, 4-HYDROXY ALVERINE, DERIVATIVE THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

enthalten in: Europäisches Patentamt | 2023

von KWON KI-SUN | LEE YOUNGLANG | YOON JONG HYUN | +4

4

Pharmaceutical composition for preventing or treating muscular weakness-related diseases comprising alverine, 4-hydroxy alverine, derivative thereof, or pharmaceutically acceptable salt thereof

enthalten in: Europäisches Patentamt | 2022

von KWON KI-SUN | LEE YOUNGLANG | YOON JONG HYUN | +4

5

Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype

enthalten in: The Journal of clinical investigation | 2022

von Lee, Y. | Wessel, A. | Xu, J. | +20

CommentIn: Nat Rev Rheumatol. 2022 May;18(5):245. - PMID 35383315

6

Alverine citrate promotes myogenic differentiation and ameliorates muscle atrophy

enthalten in: Biochemical and biophysical research communications | 2022

von Yoon, J. | Lee, S. | Lee, Y. | +7

7

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUSCULAR WEAKNESS-RELATED DISEASES COMPRISING ALVERINE, 4-HYDROXY ALVERINE, DERIVATIVE THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

enthalten in: Europäisches Patentamt | 2021

von KWON KI-SUN | LEE YOUNGLANG | YOON JONG HYUN | +4

8

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUSCULAR WEAKNESS-RELATED DISEASES COMPRISING ALVERINE, 4-HYDROXY ALVERINE, DERIVATIVE THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

enthalten in: Europäisches Patentamt | 2021

von KWON KI-SUN | LEE YOUNGLANG | YOON JONG HYUN | +4

9

FABP3-mediated membrane lipid saturation alters fluidity and induces ER stress in skeletal muscle with aging

enthalten in: Nature communications | 2020

von Lee, S. | Lee, S. | Jung, Y. | +9

10

Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2016

von Zilberman-Rudenko, J. | Shawver, L. | Wessel, A. | +10

CommentIn: Nat Rev Rheumatol. 2016 Mar;12(3):134. - PMID 26865109